Today Community Catalyst launched a new section of our website, “Stories from the States: the Impact of the ACA Implementation Fund.” Dedicated to showcasing the success state advocates have had in their work to ensure effective and consumer-focused imple

The Sickle Cell Treatment Act (SCTA) provides an important opportunity to advocate for implementing public policies that will lead to better care and health outcomes for individuals living with sickle cell disease (SCD). In 2003, Senators Jim Talent (R-MO

Recently, old arguments about the appropriate role of the hospital emergency room (ER) in our health care system have resurfaced as the nation considers its next President. Given the high profile of the issue and the wide array of public opinions on the m

September 30 is upon us. Has your state e-filed their Essential Health Benefits (EHB) plan? The ACA requires that all new, non-grandfathered plans in the individual and small group markets both inside and outside the Exchange offer a standard package of b

Frequent readers of this blog will know that we’ve written previously on Essential Health Benefits (EHB), a minimum set of core benefits the Affordable Care Act (ACA) requires most plans to cover starting in 2014. States are in the process of choosing a b

This entry was originally posted on the Center on Health Insurance Reforms at Georgetown University Health Policy Institute's CHIRblog. As of September 23, the “wild west” of shopping for health insurance coverage has been at least partially tamed, thanks

Provisions in the Affordable Care Act (ACA) address a challenge many across the nation are trying to tackle – advancing health equity by improving the health status of and quality of care for racial and ethnic minorities. A recent report issued by the Nat

Yesterday, DPH issued temporary regulations that, unless changed, will gut the state’s drug and device marketing regulations, which were proudly heralded in 2008 as a step toward curbing drug industry marketing abuses and addressing spiraling health care

Yesterday, DPH issued temporary regulations that, unless changed, will gut the state’s drug and device marketing regulations, which were proudly heralded in 2008 as a step toward curbing drug industry marketing abuses and addressing spiraling health care